Family No. | Nucleotide change1 | Amino acid change | Mutation type | Exon | Allele frequency in 1846 controls | dbSNP | EVS | PhyloP2[-14,1;6,4] | Grantham distance3[0–215] | In-silico predictions4 | Novel variant | Pathogenicity class5 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Patients with 2 pathogenic or likely pathogenic SACS variants | ||||||||||||
#1 index | c.9305_9306insT | p.Leu3102Phefs*8 | frame shift | 10 | 0 | - | - | NA | NA | NA | yes | Pathogenic (class 5) |
c.9305_9306insT | p.Leu3102Phefs*8 | |||||||||||
#1 sister | see above | |||||||||||
#2 | c.2182C>T | p.Arg728* | nonsense | 9 | 0 | - | - | ND | NA | NA | no6 | Pathogenic (class 5) |
c.13056delT | p.Phe4352Leufs*11 | frame shift | 10 | 0 | - | - | NA | NA | NA | yes | Pathogenic (class 5) | |
#3 index | c.3769G>T | p.Gly1257* | nonsense | 10 | 0 | - | - | ND | NA | NA | yes | Pathogenic (class 5) |
c. 8584A>T | p.Lys2862* | nonsense | 10 | 0 | - | - | ND | NA | NA | yes | Pathogenic (class 5) | |
#3 sister | see above | |||||||||||
#4 index | c.11542_11544del | p.Ile3848del | in-frame deletion | 10 | 0 | - | - | NA | NA | NA | yes | Likely pathogenic (VUS class 4) |
c.11542_11544del | p.Ile3848del | |||||||||||
#4 brother | see above | |||||||||||
#5 index | c.2387delT | p.Leu796Tyrfs*13 | frame shift | 10 | 0 | - | - | NA | NA | NA | yes | Pathogenic (class 5) |
c.11984_11986 dupTGT | p.L3995dup | in-frame duplication | 10 | 0 | - | - | NA | NA | NA | yes | Likely pathogenic (VUS class 4) | |
#5 sister | see above | |||||||||||
#6 | c.11624 G>A | p.Arg3875His | missense | 10 | 0 | - | - | 6.34 | 29 | Deleterious | yes | Likely pathogenic (VUS class 4) |
c.1647_1658del | p.Leu549_Leu552del | In-frame deletion | 8 | 0 | - | - | NA | NA | NA | yes | Likely pathogenic (VUS class 4) | |
c.13538 G>A | p.Ser4513Asn | missense | 10 | 0 | rs138328181 (0% ESP Cohort pop) | 0.02% (EA), 0% (AA) | 3.43 | 46 | Contradictory | yes | Uncertain (VUS class 3) | |
#7 | c.5544dupA | p.Val1849Serfs*48 | frame shift | 10 | 0 | - | - | NA | NA | NA | yes | Pathogenic (class 5) |
c.12603C>A | p.Tyr4201* | nonsense | 10 | 0 | - | - | ND | NA | NA | yes | Pathogenic (class 5) | |
#8 | c.7277 G>C | p.Arg2426Pro | missense | 10 | 0 | - | - | 5.69 | 103 | Deleterious | yes | Likely pathogenic (VUS class 4) |
c.8920_8923dup | p.Tyr2975Phefs*29 | frame shift | 10 | 0 | - | - | NA | NA | NA | yes | Pathogenic (class 5) | |
#9 | c.4954C>T | p.Gln1652* | nonsense | 10 | 0 | - | - | ND | NA | NA | yes | Pathogenic (class 5) |
c.5125C>T | p.Gln1709* | nonsense | 10 | 0 | - | - | ND | NA | NA | no6 | Pathogenic (class 5) | |
Patients with 2 SACS variants of uncertain clinical significance class 3 (VUS3) | ||||||||||||
#10 | c.1373C>T | p.Thr458Ile | missense | 8 | 14/3500 | rs61729954 (0.3% ESP Cohort pop; 3.1% AGI ASP pop) | 0.33% (EA); 0.05% (AA) | 6.26 | 89 | Deleterious | yes | Uncertain (VUS class 3) |
c.1373C>T | p.Thr458Ile | |||||||||||
#11 | c.1373C>T (see patient #10) | p.Thr458Ile | missense | 8 | 14/3500 | rs61729954 (0.3% ESP Cohort pop; 3.1% AGI ASP pop) | 0.33% (EA); 0.05% (AA) | 6.26 | 89 | Deleterious | yes | Uncertain (VUS class 3) |
c.2983 G>T | p.Val995Phe | missense | 10 | 11/3500 | rs142967124 (0.1% ESP Cohort pop) | 0.24% (EA); 0.02% (AA) | -0.2 | 50 | Contradictory | yes | Uncertain (VUS class 3) |